Hesse, M <br/><br/>
NOS-2 mediates the protective anti-inflammatory and antifibrotic effects of the Th1-inducing adjuvant, IL-12, in a Th2 model of granulomatous disease.  [electronic resource] 

 -  The American journal of pathology  Sep 2000 
 - 945-55 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>0002-9440 
<br/><br/><label>Standard No.: </label>10.1016/S0002-9440(10)64607-X  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adjuvants, Immunologic--pharmacology<br/>Animals<br/>Cells, Cultured<br/>Disease Models, Animal<br/>Female<br/>Granuloma--immunology<br/>Interferon-gamma--deficiency<br/>Interleukin-12--pharmacology<br/>Liver Cirrhosis, Experimental--immunology<br/>Lymphocyte Activation<br/>Mice<br/>Mice, Inbred C57BL<br/>Mice, Knockout<br/>Nitric Oxide Synthase--deficiency<br/>Nitric Oxide Synthase Type II<br/>RNA, Messenger--metabolism<br/>Reverse Transcriptase Polymerase Chain Reaction<br/>Schistosomiasis mansoni--immunology<br/>Spleen--cytology<br/>Th1 Cells--immunology<br/>Th2 Cells--immunology